
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
focusing on the development and commercialization of High Barrier to Entry generic drugs. TWi focuses primarily on the development of Paragraph IV and high technical barrier generic drugs requiring strong science and technical know-how, as well as under-serviced mature molecules to meet market needs. For more information about TWi Corporate and High Barrier to Entry generics, please click here to visit www.twipharma.com. Our goals are to expand our market presence in the United States as a strong industry partner, and to continue to identify, acquire, develop, license and launch technically challenging or mature molecule generic drugs
Twi pharmaceuticals, inc operates in the Pharmaceutical manufacturing industry.
Twi pharmaceuticals, inc's revenue is 11m - 100m
Twi pharmaceuticals, inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.